Robert A. Copeland, EVP and CSO at Epizyme, Inc. (EPZM), sold 38,400 shares at $22.21 ($856K) on 2014-06-02, disclosed to the SEC on 2014-06-04.
Scheduled sale ($856k) by EVP and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.21 | 35,300 | $784K | 91.6% |
| 2 | $23.21 | 3,100 | $72K | 8.4% |
| Total | $22.29 avg | 38,400 | $856K | 100% |
| Filing → |
| EPZM | SELL | 2017-04-05 | $41K | — | Filing → |
| EPZM | SELL | 2016-08-03 | $83K | — | Filing → |
| EPZM | SELL | 2016-07-07 | $80K | — | Filing → |